Cargando…
Economic analysis of opportunities to accelerate Alzheimer’s disease research and development
The development of disease-modifying treatments for Alzheimer's disease (AD) faces a number of barriers. Among these are the lack of surrogate biomarkers, the exceptional size and duration of clinical trials, difficulties in identifying appropriate populations for clinical trials, and the limit...
Autores principales: | Scott, Troy J, O'Connor, Alan C, Link, Albert N, Beaulieu, Travis J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285871/ https://www.ncbi.nlm.nih.gov/pubmed/24673372 http://dx.doi.org/10.1111/nyas.12417 |
Ejemplares similares
-
Insights from the evaluations of the NIH Centers for Accelerated Innovation and Research Evaluation and Commercialization Hubs programs
por: Anderson, Benjamin J., et al.
Publicado: (2021) -
Advancing Data Capacity for Economic Outcomes in Patient-Centered Outcomes Research: Challenges and Opportunities
por: Timbie, Justin W., et al.
Publicado: (2023) -
Microbiology challenges and opportunities in the circular economy
por: O'Connor, Kevin E.
Publicado: (2021) -
Integrating Environment and Aging Research: Opportunities for Synergy and Acceleration
por: Malecki, Kristen M. C., et al.
Publicado: (2022) -
Accelerating science and innovation: societal benefits of European research in Particle Physics
por: Radford, Tim, et al.
Publicado: (2013)